Loading…

Heparin-induced thrombocytopenia and the use of r-hirudin during cardiopulmonary bypass

We report the successful use of r-hirudin (lepirudin) for cardiopulmonary bypass in a 67-year-old man who developed heparin-induced thrombocytopenia type II during heparin treatment of an extensive deep venous thrombosis. Lepirudin was monitored by the modified ecarin clotting time in a "mobile...

Full description

Saved in:
Bibliographic Details
Published in:Anaesthesia and intensive care 2005-06, Vol.33 (3), p.388-392
Main Authors: MANIKAPPA, S, BENFIELD, K, GAN, T. E, BUTLER, J, MALAN, E, TRAN, H. A. M, TUCKER, A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We report the successful use of r-hirudin (lepirudin) for cardiopulmonary bypass in a 67-year-old man who developed heparin-induced thrombocytopenia type II during heparin treatment of an extensive deep venous thrombosis. Lepirudin was monitored by the modified ecarin clotting time in a "mobile laboratory" set up next to the cardiac theatre, aiming for lepirudin levels of 3.5 to 4.5 microg/ml during bypass.
ISSN:0310-057X
1448-0271
DOI:10.1177/0310057x0503300316